Target intelligence / Profile preview

Streptococcus pneumoniae type 9V capsular polysaccharide (CPS 9V)

Target
CPS 9V
Molecular classification
Polysaccharide, Capsular Polysaccharide, Antigen
01

Overview

The Streptococcus pneumoniae type 9V capsular polysaccharide (CPS) is a high molecular weight polymer forming the bacterium's outer layer. This capsule is a major virulence factor that protects the organism from host immune responses. It's a key component of vaccines used to prevent pneumococcal diseases. The repeating unit is a pentasaccharide, and the polymer is partially O-acetylated, affecting immunogenicity. Biosynthesis is Wzx/Wzy-dependent. Type-specific antibodies recognize structural features including O-acetate modifications, and immunization induces protective immunity against S. pneumoniae type 9V.

Other names
Streptococcus pneumoniae Type 9V Capsular Polysaccharide AntigenPneumococcal Capsular Polysaccharide Type 9V VaccinePneumococcal Polysaccharide Powder Type 9V
02

Mechanism of action

Antibodies bind to the polysaccharide capsule, promoting opsonophagocytosis and complement-mediated killing of the bacteria. Vaccines elicit the production of such antibodies.

03

Biological functions

Virulence factorImmune evasionAntigen presentationProtective immunity induction
04

Disease associations

Pneumococcal pneumoniaBacteremiaInfection
05

Safety considerations

Vaccine side effects (e.g., local reactions, fever)Potential for serotype replacement after vaccinationLimited efficacy in certain populations (e.g., immunocompromised individuals)
06

Interacting drugs

Pneumococcal vaccines (containing type 9V CPS)

1 more in the full profile.

07

Biomarkers

Anti-type 9V CPS antibody titers (IgG)Presence of S. pneumoniae type 9V in clinical samples

Beyond the preview

Go deeper on Streptococcus pneumoniae type 9V capsular polysaccharide (CPS 9V).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Streptococcus pneumoniae type 9V capsular polysaccharide (CPS 9V).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call